脑梗死恢复期的临床路径实施效果分析

Analysis of Clinical Path Implementation in the Recovery Period of Cerebral Infarction

目的通过对脑梗死恢复期实施临床路径管理的患者与未实施临床路径管理的患者医疗费用结构的变化的分析,探讨临床路径实施效果,为优化该病种诊疗模式提供参考依据。方法 HIS系统随机调取2017年1月～2018年6月诊断为脑梗死恢复期患者的住院资料,其中292例入临床路径管理,设为临床路径组,328例未入临床路径管理,设为非临床路径组,分别记录两组患者平均住院费用、药品费用、材料费用及住院日情况进行对比分析。结果脑梗死恢复期临床路径组患者平均住院费用、药品费用、材料费用及住院日较非临床路径组患者下降,统计学意义显著(P<0.01)。结论实施临床路径管理能有效降低脑梗死恢复期患者住院各项费用,缩短住院日,规范医护人员临床诊疗行为,保障医疗安全。

Objective To analyze the changes in the medical cost structure of patients who underwent clinical path management during the recovery period of cerebral infarction and the patients who did not implement clinical pathway management,and to provide a reference for optimizing the diagnosis and treatment mode of the disease.Methods The HIS system randomly selected hospitalization data of patients diagnosed with cerebral infarction during the recovery period from January 2017 to June 2018. Of these,292 were included in the clinical pathway management, and were included in the clinical pathway group.328 cases were not included in the clinical path management, and were set as non-clinical path group.The average hospitalization cost,drug cost, material cost and hospitalization day of the two groups were recorded for comparative analysis.Results The average hospitalization cost,drug cost,material cost and hospitalization day of the patients in the clinical pathology group were significantly lower than those in the nonclinical path group,with statistical significance （P〈0.01）.Conclusion The implementation of clinical pathway management can effectively reduce the cost of hospitalization for patients with cerebral infarction,shorten the hospitalization day,standardize the clinical diagnosis and treatment behavior of medical staff, and ensure medical safety.